Gujarat Kidney And Super Speciality (NSE:GKSL) Total Stockholders Equity: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
21 GF Score
Price ₹173.60
! 8 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality Total Stockholders Equity?

Gujarat Kidney And Super Speciality NSE:GKSL +1.47% 21 Total Stockholders Equity is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 21/100. The stock has 8 warning signs investors should review.

Gujarat Kidney And Super Speciality's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Gujarat Kidney And Super Speciality's Book Value per Share for the quarter that ended in Jun. 2026 was ₹N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Gujarat Kidney And Super Speciality's Debt-to-Equity for the quarter that ended in Jun. 2026 was .

Gujarat Kidney And Super Speciality  (NSE:GKSL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Gujarat Kidney And Super Speciality's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-)/78.84325
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Gujarat Kidney And Super Speciality's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + 0) /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality Total Stockholders Equity Related Terms

Gujarat Kidney And Super Speciality Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality Total Stockholders Equity Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
3.70 108.04 259.36 2,525.12

Gujarat Kidney And Super Speciality Quarterly Data
Jun25 Dec25 Mar26 Jun26
Total Stockholders Equity 0.00 0.00 2,525.12 0.00
NSE:GKSL
21GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₹0 Mil mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a Total Stockholders Equity of ₹0 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Gujarat Kidney And Super Speciality and its competitors.
Is Gujarat Kidney And Super Speciality's Total Stockholders Equity too high?
Gujarat Kidney And Super Speciality's current Total Stockholders Equity is ₹0 Mil. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's Total Stockholders Equity compare to HCA and THC?
Gujarat Kidney And Super Speciality's Total Stockholders Equity of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Gujarat Kidney And Super Speciality and its competitors. Gujarat Kidney And Super Speciality's current Total Stockholders Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current Total Stockholders Equity of ₹0 Mil. The current Total Stockholders Equity is ₹0 Mil. Gujarat Kidney And Super Speciality's overall GF Score™ is 21/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current Total Stockholders Equity is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
21GF Score

Get the complete analysis for NSE:GKSL

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹173.60
Price